Menu
Search
|

Menu

Close
X

Origo Acquisition Corp OACQ.OQ (NASDAQ Stock Exchange Capital Market)

10.75 USD
-0.25 (-2.27%)
As of 8:59 PM GMT
chart
Previous Close 11.00
Open 10.75
Volume 100
3m Avg Volume 2,573
Today’s High 10.75
Today’s Low 10.75
52 Week High 11.50
52 Week Low 10.10
Shares Outstanding (mil) 5.28
Market Capitalization (mil) 55.76
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue (mm, USD)
FY17
0
FY16
0
FY15
0
EPS (USD)
FY17
-0.310
FY16
-0.379
FY15
-0.214
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.90
Price to Sales (TTM)
vs sector
--
5.77
Price to Book (MRQ)
vs sector
4.46
5.41
Price to Cash Flow (TTM)
vs sector
--
23.42
Total Debt to Equity (MRQ)
vs sector
10.34
16.52
LT Debt to Equity (MRQ)
vs sector
0.00
12.22
Return on Investment (TTM)
vs sector
-2.81
14.43
Return on Equity (TTM)
vs sector
-17.27
16.13

EXECUTIVE LEADERSHIP

Edward Fred
President, Chief Executive Officer, Director, Since 2016
Salary: --
Bonus: --
Jose Aldeanueva
Chief Financial Officer, Treasurer, Secretary, Director, Since 2016
Salary: --
Bonus: --
Jeffrey Gutovich
Director, Since 2016
Salary: --
Bonus: --
Stephen Pudles
Director, Since 2016
Salary: --
Bonus: --
Barry Rodgers
Director, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

24 New England Executive Park St
BURLINGTON   MA   01803-5203

Phone: +1781.6524500
Site:

Origo Acquisition Corporation, formerly CB Pharma Acquisition Corp., is a shell company. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company focuses on identifying a business to a particular industry or geographic region of the world. The Company is not engaged in any business operations. As of November 30, 2016, the Company had not generated any revenues.

SPONSORED STORIES